Production (Stage)
Guardant Health, Inc.
GH
$38.00
$0.952.56%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 28.20% | 31.04% | 29.20% | 26.20% | 25.21% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 28.20% | 31.04% | 29.20% | 26.20% | 25.21% |
| Cost of Revenue | 25.06% | 27.64% | 29.80% | 32.54% | 34.87% |
| Gross Profit | 30.27% | 33.34% | 28.82% | 22.29% | 19.60% |
| SG&A Expenses | 27.31% | 20.93% | 10.38% | -2.30% | -5.37% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.98% | 13.17% | 6.97% | 1.50% | 1.15% |
| Operating Income | -1.80% | 7.78% | 16.19% | 21.61% | 19.72% |
| Income Before Tax | 9.71% | 9.12% | -19.02% | 3.26% | 30.66% |
| Income Tax Expenses | 37.53% | 87.45% | -98.52% | -66.48% | -39.42% |
| Earnings from Continuing Operations | 9.62% | 8.98% | -18.52% | 3.44% | 30.68% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 9.62% | 8.98% | -18.52% | 3.44% | 30.68% |
| EBIT | -1.80% | 7.78% | 16.19% | 21.61% | 19.72% |
| EBITDA | -2.33% | 8.43% | 17.77% | 23.81% | 22.01% |
| EPS Basic | 13.87% | 16.91% | -4.21% | 16.79% | 39.62% |
| Normalized Basic EPS | -0.96% | 14.53% | 27.16% | 34.63% | 45.95% |
| EPS Diluted | 13.87% | 16.91% | -4.21% | 16.79% | 39.62% |
| Normalized Diluted EPS | -0.96% | 14.53% | 27.16% | 34.63% | 45.95% |
| Average Basic Shares Outstanding | 5.65% | 9.66% | 12.51% | 15.40% | 13.98% |
| Average Diluted Shares Outstanding | 5.65% | 9.66% | 12.51% | 15.40% | 13.98% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |